Ward Heggermont

Assistant Professor

Dr Ward Heggermont obtained his MD in 2009 at the KU Leuven (BE). He worked as a student-researcher in the Rega Institute (BE) from 2004 until 2007, where he developed an interest in virology, biochemistry and epigenetics. After a year of clinical traineeship, he started a research project supported by the Fonds Wetenschappelijk Onderzoek Vlaanderen (BE), Prof. Stephane Heymans being his mentor at the KU Leuven (BE) and Maastricht University (NL). This resulted in a PhD in 2016. In 2015-2017, he continued his clinical training in cardiology at the OLV Hospital Aalst (BE). During his training, he continued his scientific research supported by the Fund Prof. Frans Van de Werf for Cardiovascular Research. He also obtained a Master in Specialist Medicine (MMed) and Hospital Management (MSc) (KU Leuven).

Within cardiology, his interest is focussed on diverse aspects of heart failure. In this regard, he did an additional fellowship for cardiac resynchronisation therapy in the Cardiocentro Ticino (Lugano, Switzerland) guided by Prof. Angelo Auricchio.

Since 2018, he has been appointed staff member in the OLV Aalst Heart Center, particularly focussing on heart failure (cardiomyopathies, cardiogenetics). He continues his scientific research in the OLV Aalst Heart Center and at CARIM, focussing on epigenetics and biomarker research.

Department of Cardiology    
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
Room number: 3232
T: +31(0)43 388 29 49

  • 2020
    • Wagner, M., Bertero, E., Nickel, A., Kohlhaas, M., Gibson, G. E., Heggermont, W., Heymans, S., & Maack, C. (2020). Selective NADH communication from alpha-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart. Basic Research in Cardiology, 115(5), [53]. https://doi.org/10.1007/s00395-020-0815-1
    • Heggermont, W., Pham Anh Hong Nguyen, Lau, C-W., & Tournoy, K. (2020). A Steep Increase in the HeartLogic Index Predicts COVID-19 Disease in an Advanced Heart Failure Patient. Case reports in cardiology, 2020, [8896152]. https://doi.org/10.1155/2020/8896152
    • Heggermont, W. A., Delrue, L., Dierickx, K., Dierckx, R., Verstreken, S., Goethals, M., Bartunek, J., & Vanderheyden, M. (2020). Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients. Transplantation Direct, 6(5), [549]. https://doi.org/10.1097/TXD.0000000000000995
  • 2019
    • Heggermont, W., Auricchio, A., & Vanderheyden, M. (2019). Biomarkers to predict the response to cardiac resynchronization therapy. EP Europace, 21(11), 1609-1620. https://doi.org/10.1093/europace/euz168
  • 2018
    • Remels, A. H. V., Derks, W. J. A., Cillero-Pastor, B., Verhees, K. J. P., Kelders, M. C., Heggermont, W., Carai, P., Summer, G., Ellis, S. R., de Theije, C. C., Heeren, R. M. A., Heymans, S., Papageorgiou, A. P., & van Bilsen, M. (2018). NF-kappa B-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1864(8), 2579-2589. https://doi.org/10.1016/j.bbadis.2018.04.022
    • Deckx, S., Heggermont, W., Carai, P., Rienks, M., Dresselaers, T., Himmelreich, U., van Leeuwen, R., Lommen, W., van der Velden, J., Gonzalez, A., Diez, J., Papageorgiou, A-P., & Heymans, S. (2018). Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation. Matrix Biology, 66, 110-124. https://doi.org/10.1016/j.matbio.2017.09.002
  • 2017
    • Heggermont, W. A., Papageorgiou, A-P., Quaegebeur, A., Deckx, S., Carai, P., Verhesen, W., Eelen, G., Schoors, S., van Leeuwen, R., Alekseev, S., Elzenaar, I., Vinckier, S., Pokreisz, P., Walravens, A-S., Gijsbers, R., Van Den Haute, C., Nickel, A., Schroen, B., van Bilsen, M., ... Heymans, S. (2017). Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. Circulation, 136(8), 747-761. https://doi.org/10.1161/CIRCULATIONAHA.116.024171
  • 2016
    • Heggermont, W. A., Papageorgiou, A-P., Heymans, S., & van Bilsen, M. (2016). Metabolic support for the heart: complementary therapy for heart failure?European journal of heart failure, 18(12), 1420-1429. https://doi.org/10.1002/ejhf.678
  • 2012